MEDINET Co., Ltd.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4587.T has a market cap of 248.40B. Regarding current trading prices, 2370.T is priced at $31.00, while 4587.T trades at $1,916.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4587.T's P/E ratio is 16.56. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4587.T's ROE of +0.28%. Regarding short-term risk, 2370.T is more volatile compared to 4587.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4592.T has a market cap of 177.73B. Regarding current trading prices, 2370.T is priced at $31.00, while 4592.T trades at $2,468.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4592.T's P/E ratio is -58.85. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4592.T's ROE of -1.82%. Regarding short-term risk, 2370.T is less volatile compared to 4592.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 2160.T has a market cap of 118.55B. Regarding current trading prices, 2370.T is priced at $31.00, while 2160.T trades at $2,361.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 2160.T's P/E ratio is 111.95. In terms of profitability, 2370.T's ROE is -0.26%, compared to 2160.T's ROE of +0.03%. Regarding short-term risk, 2370.T is more volatile compared to 2160.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4974.T has a market cap of 99.58B. Regarding current trading prices, 2370.T is priced at $31.00, while 4974.T trades at $827.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4974.T's P/E ratio is -2017.07. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4974.T's ROE of -0.00%. Regarding short-term risk, 2370.T is more volatile compared to 4974.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4565.T has a market cap of 78.75B. Regarding current trading prices, 2370.T is priced at $31.00, while 4565.T trades at $876.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4565.T's P/E ratio is -34.11. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4565.T's ROE of -0.07%. Regarding short-term risk, 2370.T is more volatile compared to 4565.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4894.T has a market cap of 54.39B. Regarding current trading prices, 2370.T is priced at $31.00, while 4894.T trades at $6,720.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4894.T's P/E ratio is -69.70. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4894.T's ROE of -0.13%. Regarding short-term risk, 2370.T is more volatile compared to 4894.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4593.T has a market cap of 32.67B. Regarding current trading prices, 2370.T is priced at $31.00, while 4593.T trades at $322.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4593.T's P/E ratio is -6.73. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4593.T's ROE of -1.58%. Regarding short-term risk, 2370.T is less volatile compared to 4593.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 7774.T has a market cap of 25.46B. Regarding current trading prices, 2370.T is priced at $31.00, while 7774.T trades at $627.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 7774.T's P/E ratio is -380.00. In terms of profitability, 2370.T's ROE is -0.26%, compared to 7774.T's ROE of -0.03%. Regarding short-term risk, 2370.T is more volatile compared to 7774.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4563.T has a market cap of 25.32B. Regarding current trading prices, 2370.T is priced at $31.00, while 4563.T trades at $67.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4563.T's P/E ratio is -0.56. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4563.T's ROE of -1.50%. Regarding short-term risk, 2370.T is less volatile compared to 4563.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4575.T has a market cap of 19.50B. Regarding current trading prices, 2370.T is priced at $31.00, while 4575.T trades at $1,021.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4575.T's P/E ratio is -14.32. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4575.T's ROE of -0.28%. Regarding short-term risk, 2370.T is less volatile compared to 4575.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4599.T has a market cap of 19.20B. Regarding current trading prices, 2370.T is priced at $31.00, while 4599.T trades at $309.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4599.T's P/E ratio is -9.21. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4599.T's ROE of -0.24%. Regarding short-term risk, 2370.T is more volatile compared to 4599.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 7776.T has a market cap of 18.10B. Regarding current trading prices, 2370.T is priced at $31.00, while 7776.T trades at $522.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 7776.T's P/E ratio is -20.77. In terms of profitability, 2370.T's ROE is -0.26%, compared to 7776.T's ROE of -0.40%. Regarding short-term risk, 2370.T is more volatile compared to 7776.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4588.T has a market cap of 13.92B. Regarding current trading prices, 2370.T is priced at $31.00, while 4588.T trades at $560.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4588.T's P/E ratio is -7.26. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4588.T's ROE of -0.86%. Regarding short-term risk, 2370.T is more volatile compared to 4588.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4889.T has a market cap of 13.83B. Regarding current trading prices, 2370.T is priced at $31.00, while 4889.T trades at $1,088.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4889.T's P/E ratio is -58.56. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4889.T's ROE of +0.07%. Regarding short-term risk, 2370.T is less volatile compared to 4889.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 7096.T has a market cap of 13.37B. Regarding current trading prices, 2370.T is priced at $31.00, while 7096.T trades at $1,305.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 7096.T's P/E ratio is 31.60. In terms of profitability, 2370.T's ROE is -0.26%, compared to 7096.T's ROE of +0.14%. Regarding short-term risk, 2370.T is less volatile compared to 7096.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4978.T has a market cap of 12.97B. Regarding current trading prices, 2370.T is priced at $31.00, while 4978.T trades at $137.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4978.T's P/E ratio is -107.87. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4978.T's ROE of -0.01%. Regarding short-term risk, 2370.T is more volatile compared to 4978.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4880.T has a market cap of 12.88B. Regarding current trading prices, 2370.T is priced at $31.00, while 4880.T trades at $650.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4880.T's P/E ratio is 54.30. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4880.T's ROE of +0.01%. Regarding short-term risk, 2370.T is more volatile compared to 4880.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4888.T has a market cap of 11.09B. Regarding current trading prices, 2370.T is priced at $31.00, while 4888.T trades at $326.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4888.T's P/E ratio is -14.21. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4888.T's ROE of -0.24%. Regarding short-term risk, 2370.T is less volatile compared to 4888.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4579.T has a market cap of 10.68B. Regarding current trading prices, 2370.T is priced at $31.00, while 4579.T trades at $437.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4579.T's P/E ratio is -19.12. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4579.T's ROE of -0.09%. Regarding short-term risk, 2370.T is less volatile compared to 4579.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4875.T has a market cap of 10.64B. Regarding current trading prices, 2370.T is priced at $31.00, while 4875.T trades at $217.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4875.T's P/E ratio is -6.57. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4875.T's ROE of -7.57%. Regarding short-term risk, 2370.T is more volatile compared to 4875.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4571.T has a market cap of 9.53B. Regarding current trading prices, 2370.T is priced at $31.00, while 4571.T trades at $135.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4571.T's P/E ratio is -14.92. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4571.T's ROE of -0.20%. Regarding short-term risk, 2370.T is less volatile compared to 4571.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4583.T has a market cap of 9.35B. Regarding current trading prices, 2370.T is priced at $31.00, while 4583.T trades at $138.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4583.T's P/E ratio is -7.87. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4583.T's ROE of -0.75%. Regarding short-term risk, 2370.T is less volatile compared to 4583.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 177A.T has a market cap of 8.78B. Regarding current trading prices, 2370.T is priced at $31.00, while 177A.T trades at $1,717.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 177A.T's P/E ratio is 18.59. In terms of profitability, 2370.T's ROE is -0.26%, compared to 177A.T's ROE of +0.14%. Regarding short-term risk, 2370.T is more volatile compared to 177A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 206A.T has a market cap of 8.65B. Regarding current trading prices, 2370.T is priced at $31.00, while 206A.T trades at $236.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 206A.T's P/E ratio is -7.04. In terms of profitability, 2370.T's ROE is -0.26%, compared to 206A.T's ROE of -0.32%. Regarding short-term risk, 2370.T is more volatile compared to 206A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4896.T has a market cap of 8.62B. Regarding current trading prices, 2370.T is priced at $31.00, while 4896.T trades at $743.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4896.T's P/E ratio is -10.18. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4896.T's ROE of -0.33%. Regarding short-term risk, 2370.T is more volatile compared to 4896.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 2183.T has a market cap of 6.64B. Regarding current trading prices, 2370.T is priced at $31.00, while 2183.T trades at $294.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 2183.T's P/E ratio is -54.85. In terms of profitability, 2370.T's ROE is -0.26%, compared to 2183.T's ROE of -0.03%. Regarding short-term risk, 2370.T is more volatile compared to 2183.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4564.T has a market cap of 6.34B. Regarding current trading prices, 2370.T is priced at $31.00, while 4564.T trades at $23.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4564.T's P/E ratio is -4.78. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4564.T's ROE of -1.40%. Regarding short-term risk, 2370.T is less volatile compared to 4564.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4893.T has a market cap of 6.15B. Regarding current trading prices, 2370.T is priced at $31.00, while 4893.T trades at $142.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4893.T's P/E ratio is -6.37. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4893.T's ROE of -0.19%. Regarding short-term risk, 2370.T is more volatile compared to 4893.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4584.T has a market cap of 6.05B. Regarding current trading prices, 2370.T is priced at $31.00, while 4584.T trades at $127.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4584.T's P/E ratio is -5.72. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4584.T's ROE of -1.00%. Regarding short-term risk, 2370.T is more volatile compared to 4584.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 3750.T has a market cap of 5.89B. Regarding current trading prices, 2370.T is priced at $31.00, while 3750.T trades at $660.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 3750.T's P/E ratio is 39.59. In terms of profitability, 2370.T's ROE is -0.26%, compared to 3750.T's ROE of -0.02%. Regarding short-term risk, 2370.T is more volatile compared to 3750.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4891.T has a market cap of 5.79B. Regarding current trading prices, 2370.T is priced at $31.00, while 4891.T trades at $133.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4891.T's P/E ratio is -4.67. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4891.T's ROE of -0.22%. Regarding short-term risk, 2370.T is more volatile compared to 4891.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4884.T has a market cap of 5.52B. Regarding current trading prices, 2370.T is priced at $31.00, while 4884.T trades at $808.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4884.T's P/E ratio is -6.83. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4884.T's ROE of -0.37%. Regarding short-term risk, 2370.T is more volatile compared to 4884.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4572.T has a market cap of 5.23B. Regarding current trading prices, 2370.T is priced at $31.00, while 4572.T trades at $274.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4572.T's P/E ratio is -2.25. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4572.T's ROE of -0.73%. Regarding short-term risk, 2370.T is more volatile compared to 4572.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4598.T has a market cap of 4.75B. Regarding current trading prices, 2370.T is priced at $31.00, while 4598.T trades at $472.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4598.T's P/E ratio is -2.16. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4598.T's ROE of -2.38%. Regarding short-term risk, 2370.T is less volatile compared to 4598.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4576.T has a market cap of 4.57B. Regarding current trading prices, 2370.T is priced at $31.00, while 4576.T trades at $101.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4576.T's P/E ratio is -2.75. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4576.T's ROE of -1.45%. Regarding short-term risk, 2370.T is more volatile compared to 4576.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4570.T has a market cap of 4.41B. Regarding current trading prices, 2370.T is priced at $31.00, while 4570.T trades at $473.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4570.T's P/E ratio is 19.03. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4570.T's ROE of +0.23%. Regarding short-term risk, 2370.T is more volatile compared to 4570.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4591.T has a market cap of 3.79B. Regarding current trading prices, 2370.T is priced at $31.00, while 4591.T trades at $85.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4591.T's P/E ratio is -3.31. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4591.T's ROE of -0.30%. Regarding short-term risk, 2370.T is more volatile compared to 4591.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4881.T has a market cap of 3.67B. Regarding current trading prices, 2370.T is priced at $31.00, while 4881.T trades at $99.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4881.T's P/E ratio is -3.10. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4881.T's ROE of -0.36%. Regarding short-term risk, 2370.T is more volatile compared to 4881.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4594.T has a market cap of 3.60B. Regarding current trading prices, 2370.T is priced at $31.00, while 4594.T trades at $39.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4594.T's P/E ratio is -2.36. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4594.T's ROE of -1.03%. Regarding short-term risk, 2370.T is less volatile compared to 4594.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 2385.T has a market cap of 3.45B. Regarding current trading prices, 2370.T is priced at $31.00, while 2385.T trades at $132.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 2385.T's P/E ratio is -8.70. In terms of profitability, 2370.T's ROE is -0.26%, compared to 2385.T's ROE of -0.06%. Regarding short-term risk, 2370.T is more volatile compared to 2385.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 2342.T has a market cap of 2.86B. Regarding current trading prices, 2370.T is priced at $31.00, while 2342.T trades at $172.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 2342.T's P/E ratio is -12.65. In terms of profitability, 2370.T's ROE is -0.26%, compared to 2342.T's ROE of -0.04%. Regarding short-term risk, 2370.T is more volatile compared to 2342.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 4596.T has a market cap of 2.65B. Regarding current trading prices, 2370.T is priced at $31.00, while 4596.T trades at $45.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 4596.T's P/E ratio is -1.90. In terms of profitability, 2370.T's ROE is -0.26%, compared to 4596.T's ROE of -0.72%. Regarding short-term risk, 2370.T is more volatile compared to 4596.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 6190.T has a market cap of 1.29B. Regarding current trading prices, 2370.T is priced at $31.00, while 6190.T trades at $319.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 6190.T's P/E ratio is -10.21. In terms of profitability, 2370.T's ROE is -0.26%, compared to 6190.T's ROE of -0.08%. Regarding short-term risk, 2370.T is less volatile compared to 6190.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.

2370.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2370.T stands at 8.21B. In comparison, 2191.T comparison data is unavailable. Regarding current trading prices, 2370.T is priced at $31.00, while 2191.T trades at $2.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2370.T currently has a P/E ratio of -6.15, whereas 2191.T's P/E ratio is -0.06. In terms of profitability, 2370.T's ROE is -0.26%, compared to 2191.T's ROE of -1.44%. Regarding short-term risk, 2370.T is less volatile compared to 2191.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2370.T.